Merit Medical Systems | MMSI - Sales Revenues


Merit Medical Systems reported $381.9M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
3M USD 6B 100M Mar/2026
Abbott USD 11.16B 300M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Anika Therapeutics USD 30.62M 2.8M Dec/2025
AtriCure USD 141.2M 700K Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
ICU Medical USD 525.77M 14.93M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Olympus JPY 295.28B 34.23B Mar/2026
Pfizer USD 14.5B 3.08B Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026